stockrowEnvoy Medical, Inc.
COCH Healthcare Medical Devices
Envoy Medical, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $241,000.00, up 7.11% from fiscal 2024.
- Revenue
- +57.1%
- EPS
- −42.9%
- Free cash flow
- −22.4%
Quarter to September 2026, against a year earlier
Follow COCH
Alert me
Envoy Medical, Inc. (COCH) EV/Sales
As of 5 November 2026, Envoy Medical, Inc. (COCH) trades at a EV/Sales of 389×. Over the past ten years it has ranged from 0.0× (June 2023) to 488× (March 2024); the current reading is higher than 95% of that period. That is above the Medical Devices industry median of 2.7× and above the Healthcare sector median of 3.5×.
EV/Sales, daily
Embed this chart
Annual newest first
| Period | EV/Sales | Change |
|---|---|---|
| FY2025 | 175× | (7.81%) |
| FY2024 | 190× | 9.06% |
| FY2023 | 174× | — |
| FY2022 | 0.0× | — |
Quarterly newest first
| Period | EV/Sales | Change |
|---|---|---|
| Sep 2026 | 376× | (16.57%) |
| Jun 2026 | 451× | 106.04% |
| Mar 2026 | 219× | 24.82% |
| Dec 2025 | 175× | (17.15%) |
| 13 more quarters | Free account |
Against its own ten years
EV/Sales against peers
| Company | EV/Sales |
|---|---|
| XTNT Xtant Medical Holdings, Inc. compare | 0.5× |
| SNWV Sanuwave Health Inc. compare | 0.7× |
| CVRX CVRx, Inc. compare | 0.7× |
| LNSR LENSAR, Inc. compare | 1.0× |
| MYO Myomo, Inc. compare | 1.1× |
| ECOR electroCore, Inc. compare | 2.1× |
| SRTS Sensus Healthcare, Inc. compare | 2.2× |
| MDAI Spectral AI, Inc. compare | 2.7× |
| COCH Envoy Medical, Inc. | 389× |
| Medical Devices industry median | 2.7× |
| Healthcare sector median | 3.5× |
| Market median | 2.1× |
What EV/Sales is
EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)